___

• Auer J, Berent R, Weber T, Lassnig E, Eber B. Thyroid function is associated with presence and severity of coronary atherosclerosis. Clin Cardiol 2003; 26(12): 569-73.
• Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease. JAMA 2004; 291(2): 228-38.
• Col NF, Surks MI, Daniels GH. Subclinical thyroid disease. JAMA 2004; 291(2): 239-43.
• Caraccio N, Ferrannini E, Monzani F. Lipoprotein profile in subclinical hypothyroidism: Response to Levothyroxine Replacement, a Randomized Placebo-Controlled Study. The journal of endoc and metab 2002; 87(4): 8.
• Adlin V. Subclinical hypothyroidism: Deciding when to treat. American Family Phsician 1998; 57(4): 776-80.
• Silva LM, Chavez J, Canalli MHB, Zanetti CR. Determination of Ig G subclasses and avidity of antithyroid peroxidase antibodies in patients with subclinical hypothyroidism-A comparison with patients with overt hypothyroidism. Hormone Research 2003; 59: 118-24.
• Kanaya AM, Harris F, Volpato S, Perzs-Stable EJ, Harris T, Bauer DC. Association between thyroid dysfunction and total cholesterol level in an older biracial population. Arch Intern Med 2002; 162: 773-9.
• Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch İntern Med 2000; 160: 526-34.
• Helfand M. Screening for subclinical thyroid disfunction in nonpregnant adults: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2004; 140(2): 128-41.
• Efstathiadou Z, Bitsis S, Milionis HJ, et al. Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? European Journal of Endocrinology 2001; 145: 705-10.
• Fatourechi V. Subclinical Thyroid Disease. Mayo Clinic Proceedings 2001; 76(4): 413-7.
• Staub JJ, Althaus BU, Engler H, et al. Spectrum of subclinical and overt hypothyroidism: Effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. The American Journal of Medicine ; 92(6): 631-42.
• Robbins SL, Kumar V. Patoloji. Çeviri Editörü: Uluoğlu Ö. Ankara 1990: 366.
• Topol EJ. Textbook of cardiovascular medicine. Philadelphia, 2002: 201.
• Onat A, Yazıcı M, Eryonucu B ve ark. TEKHARF 2002 yılı taramasının ölüm ve koroner olaylara ilişkin sonuçları. Türk Kardiyoloji Derneği Arşivi 2002; 30(11): 694-8.
• Abusamieh M, Ash J. Atherosclerosis and systemic lupus erythematosus. Cardiology in Review 2004; 12(5): 75.
• Erol Ç, Güzelsoy D, Koylan N ve ark. Türk Kardiyoloji Derneği Koroner Arter Hastalığına Yaklaşım ve Tedavi Kılavuzu Türk Kardiyoloji Derneği Arşivi 1999; 27(5): 262-72.
• Prediman K. Link between infection and atherosclerosis: Who are the culprits: Viruses, bacteria, both or neither? Circulation 2001; 103(1): 5-7.
• Bittner V. Women and coronary heart disease risk factors. Journal of cardiovascular risk 2002; 9(6): 315-22.
• Liu X-Q, Rahman A, Bagdade JD, Alaupovic P, Kannan CR. Effect of thyroid hormone on plasma apolipoproteins and apoA and apoB-containinglp particles. European Journal of Clinical Investigation 1998; 28(4): 70.
• Yıldırımkaya M, Özata M, Yılmaz K, Kılınç C, Gündoğan MA, Kutluay T. Lipoprotein(a) concentration in subclinical hypothyroidism before and after levo-thyroxine therapy. Endocrine Journal 1996; 43(6): 731-6.
• Pucci E, Chiovato L, Pinchera A. Thyroid and lipid metabolism. International Journal of Obesity 2000; 24 (suppl.2): 109-12.
• Tan KCP, Shiu SWM, Kung AWC. Effect of thyroid dysfunction on high-density lipoprotein subfraction metabolism: Roles of hepatic lipase and cholesteryl ester transfer protein. J Clin Endocrinol Metabolism 1998; 83(8): 4.
• Hak AE, Pols HAP, Visser TJ, Drexhage HA, Hofman A, Witteman JCM. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam Study. Ann Intern Med 2000; 132: 270-8.
• Luboshitzy R, Aviv A, Herer P, Lavie L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 2002; 12(5): 421-5.
• Bauer DC, Ettinger B, Browner WS. Thyroid function and serum lipids in older women: A population-based study. Am J Med 1998; 104: 546-51.
• Miura S, Iitaka M, Yoshimura H, et al. Disturbed lipid metabolism in patients with subclinical hypothyroidism: Effect of L-thyroxine therapy. Internal Medicine 1994; 33: 413-7.
• Miura S, Iitaka M, Suzuki S, et al. Decrease in serum levels of thyroid hormone in patients with coronary heart disease. Endocrine Journal 1996; 43(6): 657-63.
• Stubbs PJ, Mulrooney BD, Collinson PO, Fowler PBS, Noble MIM. Serum lipids and thyrotropin in women with coronary artery disease. European Heart Journal 1994; 15: 468-71.
• Taddei S, Caraccio N, Virdis A, et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: Beneficial effect of levothyroxine therapy. The Journal of Clinical Endocrinology and Metabolism ; 88(8): 3731-7.
• Tsimihodimos V, Bairaktari E, Tzallas C, Miltiatus G, Liberopoulos E, Elisaf M. The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinic. Thyroid 1999; 9(4): 365-8.
• Langer P, Kocan A, Tajtakova M, et al. Thyroid function and cholesterol level: Paradoxical findings in large groups of population with high cholesterol food intake. Endocrine Regulations 2003; 37: 175-80.
• Tanis B, Rudi G, Smelt HM. Effect of thyroid substitution on hypercholesterolemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies. Clin Endocr 1996; 44(6): 643-9.
• Pirich C, Müllner M, Sinzinger H. Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants. Journal of clin epidemiology 2000; 53: 623-9.
• Duntas LH. Thyroid disease and lipids. Thyroid 2002; 12(4): 287-93.
• Karlin NJ, Weintraub N, Chopra IJ. Current controversies in endocrinology: Screening of asymptomatic elderly for subclinical hypothyroidism. J Am Med Dir Assoc 2004; 5: 333-6.
• Ladenson PW, Singer PA. American thyroid guidelines for detection of thyroid dysfunction. Arch Intern Med ; 160: 1573-5.